Submit Deal
All Dealmakers
Similar Dealmakers
Partner at Skadden Arps Slate Meagher & Flom
Lawyer
Boston
Deal Bio
Market Context
Awards
Back to top
All rights reserved. Copyright © 2025 Datasite
Expertise (70)
Key Relationships
Sort
Target: JUNO THERAPEUTICS INC
Bidder: CELGENE CORPORATION
9 Service Providers
60 Dealmakers
£ 5.86 B
Value
Target: KITE PHARMA INC
Bidder: GILEAD SCIENCES
10 Service Providers
24 Dealmakers
£ 9.30 B
Target: WEWORK COMPANIES INC
Bidder: SOFTBANK GROUP CORP
4 Service Providers
16 Dealmakers
n/a
Target: WEBROOT INC
Bidder: CARBONITE INC
12 Service Providers
19 Dealmakers
£ 477 M
Target: CLEMENTIA PHARMACEUTICALS
Bidder: IPSEN
41 Dealmakers
£ 995 M
Target: NIGHTSTAR THERAPEUTICS
Bidder: BIOGEN INC
8 Service Providers
30 Dealmakers
£ 663 M
Target: ARRAY BIOPHARMA
Bidder: PFIZER INC
51 Dealmakers
£ 9.05 B
Target: GALAPAGOS NV
15 Service Providers
36 Dealmakers
£ 849 M
Target: SEMMA THERAPEUTICS
Bidder: VERTEX PHARMACEUTICALS INC
3 Service Providers
26 Dealmakers
£ 785 M
Target: ALDER BIOPHARMACEUTICALS
Bidder: LUNDBECK AS
10 Dealmakers
£ 1.56 B
Target: BIOVERATIV INC
Bidder: SANOFI SA
11 Service Providers
45 Dealmakers
£ 7.85 B
Target: ACHILLION PHARMACEUTICALS
Bidder: ALEXION PHARMACEUTICALS INC
6 Service Providers
21 Dealmakers
£ 732 M
Target: CARBONITE INC
Bidder: OPENTEXT
47 Dealmakers
£ 1.11 B
Target: ARQULE INC
Bidder: MERCK KGAA
62 Dealmakers
£ 2.05 B
14 Service Providers
33 Dealmakers
£ 3.47 B
Target: LEGG MASON INC
Bidder: FRANKLIN TEMPLETON INVESTMENTS CORPORATION
16 Service Providers
63 Dealmakers
£ 4.99 B
Target: FORTY SEVEN
48 Dealmakers
£ 3.82 B
Target: STEMLINE THERAPEUTICS
Bidder: MENARINI GROUP
44 Dealmakers
£ 541 M
Target: PORTOLA PHARMACEUTICALS
7 Service Providers
50 Dealmakers
£ 1.31 B
Target: MOMENTA PHARMACEUTICALS INC
Bidder: JOHNSON & JOHNSON
57 Dealmakers
£ 4.93 B
Target: CERSCI THERAPEUTICS INC
Bidder: ACADIA PHARMACEUTICALS
20 Dealmakers
£ 717 M
Target: AKCEA THERAPEUTICS
Bidder: IONIS PHARMACEUTICALS
£ 334 M
Target: WEWORK CHINA
Bidder: TRUSTBRIDGE PARTNERS
5 Service Providers
14 Dealmakers
£ 157 M
Target: UROVANT SCIENCES
Bidder: SUMITOVANT BIOPHARMA
13 Dealmakers
£ 144 M
Target: BOSTON DYNAMICS
Bidder: HYUNDAI MOTOR GROUP
34 Dealmakers
£ 695 M
Target: NATIONAL HOLDINGS
Bidder: B. RILEY FINANCIAL INC
Target: GW PHARMACEUTICALS PLC
Bidder: JAZZ PHARMACEUTICALS
20 Service Providers
85 Dealmakers
£ 5.27 B
Target: PANDION THERAPEUTICS INC
Bidder: MERCK & CO
28 Dealmakers
Target: FIVE PRIME THERAPEUTICS
Bidder: AMGEN INC
£ 1.36 B
Bidder: BOW CAPITAL
17 Service Providers
107 Dealmakers
£ 6.53 B
Target: STRONGBRIDGE
Bidder: XERIS PHARMACEUTICALS
53 Dealmakers
£ 188 M
Target: CONSTELLATION PHARMACEUTICALS
Bidder: MORPHOSYS AG
13 Service Providers
58 Dealmakers
£ 1.20 B
Target: TRANSLATE BIO
52 Dealmakers
£ 2.30 B
Target: AMICUS THERAPEUTICS (GENE THERAPY BUSINESS)
Bidder: ARYA SCIENCES ACQUISITION CORP IV
25 Dealmakers
£ 440 M
Target: ACCELERON PHARMA
80 Dealmakers
£ 8.53 B
Target: ASPEN TECHNOLOGY INC
Bidder: EMERSON ELECTRIC CO
49 Dealmakers
£ 8.08 B
Target: DICERNA
Bidder: NOVO NORDISK
23 Dealmakers
£ 2.45 B
Target: BOTTOMLINE
Bidder: THOMA BRAVO LLC
£ 1.96 B
Target: SIERRA ONCOLOGY
Bidder: GLAXOSMITHKLINE PLC
£ 1.52 B
Target: ANTARES PHARMA
Bidder: HALOZYME
59 Dealmakers
£ 737 M
Target: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD
46 Dealmakers
£ 9.42 B
Target: VIACYTE
42 Dealmakers
£ 265 M
Target: AERIE PHARMACEUTICALS INC
Bidder: ALCON INC
£ 650 M
Target: CINCOR PHARMA
Bidder: ASTRAZENECA PLC
79 Dealmakers
£ 1.49 B
Target: SEAGEN INC
67 Dealmakers
£ 35.70 B
Target: PROMETHEUS BIOSCIENCES INC
£ 8.70 B
Target: BELLUS HEALTH
17 Dealmakers
£ 1.61 B
Target: IVERIC BIO
Bidder: ASTELLAS PHARMA INC
22 Dealmakers
£ 4.69 B
Target: CTI BIOPHARMA
Bidder: SWEDISH ORPHAN BIOVITRUM AB (SOBI)
76 Dealmakers
£ 1.35 B
Target: INTERCEPT PHARMACEUTICALS
Bidder: ALFASIGMA SPA
31 Dealmakers
£ 649 M
Target: POINT BIOPHARMA
Bidder: ELI LILLY AND COMPANY
40 Dealmakers
£ 1.15 B
Target: MIRATI THERAPEUTICS
Bidder: BRISTOL MYERS SQUIBB COMPANY
54 Dealmakers
£ 3.84 B
Target: ENGAGESMART
Bidder: VISTA EQUITY PARTNERS
£ 3.29 B
Target: CEREVEL THERAPEUTICS
Bidder: ABBVIE INC
£ 6.89 B
Target: AMBRX INC
Target: MORPHOSYS AG
Bidder: NOVARTIS AG
103 Dealmakers
£ 2.31 B
Target: CYMABAY THERAPEUTICS
37 Dealmakers
£ 3.40 B
Target: ALPINE IMMUNE SCIENCES INC
£ 3.87 B
Target: INHIBRX
£ 1.34 B
Target: EYEBIOTECH
£ 2.35 B
Target: 23ANDME INC
Bidder: ANNE WOJCICKI
Target: R1 RCM
Bidder: TOWERBROOK CAPITAL PARTNERS LP
26 Service Providers
98 Dealmakers
£ 6.93 B
Target: G1 THERAPEUTICS
Bidder: PHARMACOSMOS THERAPEUTICS
15 Dealmakers
£ 318 M
£ 5.55 B
Target: AKOYA BIOSCIENCES
Bidder: QUANTERIX
8 Dealmakers
Target: INTRA-CELLULAR THERAPIES INC
£ 11.96 B
Target: LOGILITY INC
Bidder: APTEAN INC
£ 387 M
Target: EVERGREEN THERAGNOSTICS
Bidder: LANTHEUS
£ 200 M
Target: CHIMERIX
£ 734 M
Target: WALGREENS BOOTS ALLIANCE
Bidder: SYCAMORE PARTNERS LP
£ 18.39 B
